COMPANY
Epitogenesis Inc.
NIH awards 7
- NIH contract (government contract; not a grant and not an investment round) 75N93019C00039-0-9999-1 FY2019: $600,000 awarded for that fiscal year; activity N43 (OTHER_NIH); PI VAJDY, MICHAEL; recipient as written: EPITOGENESIS, INC., Virginia Beach, VA. NOVEL source ↗
- NIH contract (government contract; not a grant and not an investment round) 272201400031C-0-0-1 FY2014: $224,981 awarded for that fiscal year; activity N43 (OTHER_NIH); PI VAJDY, MICHAEL; recipient as written: EPITOGENESIS, INC., Virginia Beach, VA. A NUTRITIV source ↗
- NIH award 5R41AI096706-02 FY2013: $300,000 awarded for that fiscal year; activity R41 (STTR); PI VAJDY, MICHAEL SEJR; recipient as written: EPITOGENESIS, INC., Virginia Beach, VA. A novel vaccine against vaginal Chla source ↗
- NIH award 1R41AI096706-01A1 FY2012: $300,000 awarded for that fiscal year; activity R41 (STTR); PI VAJDY, MICHAEL SEJR; recipient as written: EPITOGENESIS, INC., Virginia Beach, VA. A novel vaccine against vaginal Ch source ↗
- NIH award 7F32CA132308-02 FY2010: $7,384 awarded for that fiscal year; activity F32 (OTHER_NIH); PI LEE, YEON J; recipient as written: EPITOGENESIS, INC., Virginia Beach, VA. Modulation of cellular gene expression by source ↗
- NIH award 3R43AI084690-01S1 FY2010: $145,600 awarded for that fiscal year; activity R43 (SBIR); PI VAJDY, MICHAEL SEJR; recipient as written: EPITOGENESIS, INC., Virginia Beach, VA. Mucosal Immune-enhancing Delivery source ↗
- NIH award 1R43AI084690-01 FY2009: $140,000 awarded for that fiscal year; activity R43 (SBIR); PI VAJDY, MICHAEL SEJR; recipient as written: EPITOGENESIS, INC., Virginia Beach, VA. Mucosal Immune-enhancing Delivery Sy source ↗